
    
      NSAR are used currently for the treatment of musculoskeletal manifestations at Sjögren
      Syndrome for the symptomatic release of pain. For therapy-resistant cases drugs also used in
      Rheumatoid Arthritis are used. For these drugs there is no registration for the treatment of
      Sjögren Syndrome.
    
  